Literature DB >> 34354279

Significance of bystander T cell activation in microbial infection.

Hoyoung Lee1, Seongju Jeong1, Eui-Cheol Shin2,3.   

Abstract

During microbial infection, pre-existing memory CD8+ T cells that are not specific for the infecting pathogens can be activated by cytokines without cognate antigens, termed bystander activation. Studies in mouse models and human patients demonstrate bystander activation of memory CD8+ T cells, which exerts either protective or detrimental effects on the host, depending on the infection model or disease. Research has elucidated mechanisms underlying the bystander activation of CD8+ T cells in terms of the responsible cytokines and the effector mechanisms of bystander-activated CD8+ T cells. In this Review, we describe the history of research on bystander CD8+ T cell activation as well as evidence of bystander activation. We also discuss the mechanisms and immunopathological roles of bystander activation in various microbial infections.
© 2021. Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34354279     DOI: 10.1038/s41590-021-00985-3

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  133 in total

1.  Induction of bystander T cell proliferation by viruses and type I interferon in vivo.

Authors:  D F Tough; P Borrow; J Sprent
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

Review 2.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

3.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D J Sourdive; A J Zajac; J D Miller; J Slansky; R Ahmed
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

4.  Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

Authors:  X Zhang; S Sun; I Hwang; D F Tough; J Sprent
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

5.  Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates.

Authors:  Yannick Simoni; Etienne Becht; Michael Fehlings; Chiew Yee Loh; Si-Lin Koo; Karen Wei Weng Teng; Joe Poh Sheng Yeong; Rahul Nahar; Tong Zhang; Hassen Kared; Kaibo Duan; Nicholas Ang; Michael Poidinger; Yin Yeng Lee; Anis Larbi; Alexis J Khng; Emile Tan; Cherylin Fu; Ronnie Mathew; Melissa Teo; Wan Teck Lim; Chee Keong Toh; Boon-Hean Ong; Tina Koh; Axel M Hillmer; Angela Takano; Tony Kiat Hon Lim; Eng Huat Tan; Weiwei Zhai; Daniel S W Tan; Iain Beehuat Tan; Evan W Newell
Journal:  Nature       Date:  2018-05-16       Impact factor: 49.962

Review 6.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

7.  Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.

Authors:  S Ehl; J Hombach; P Aichele; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

8.  Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response.

Authors:  C C Zarozinski; R M Welsh
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

Review 9.  Recent progress in mapping the emerging landscape of the small-cell lung cancer genome.

Authors:  Kee-Beom Kim; Colin T Dunn; Kwon-Sik Park
Journal:  Exp Mol Med       Date:  2019-12-12       Impact factor: 8.718

Review 10.  Bystander CD4+ T cells: crossroads between innate and adaptive immunity.

Authors:  Hong-Gyun Lee; Min-Zi Cho; Je-Min Choi
Journal:  Exp Mol Med       Date:  2020-08-28       Impact factor: 8.718

View more
  6 in total

Review 1.  Hair Follicle Melanocytes Initiate Autoimmunity in Alopecia Areata: a Trigger Point.

Authors:  Bo Xie; Jiayi Sun; Xiuzu Song
Journal:  Clin Rev Allergy Immunol       Date:  2022-09-19       Impact factor: 10.817

2.  CCL5-Secreting Virtual Memory CD8+ T Cells Inversely Associate With Viral Reservoir Size in HIV-1-Infected Individuals on Antiretroviral Therapy.

Authors:  Wei Hu; Yan-Jun Li; Cheng Zhen; You-Yuan Wang; Hui-Huang Huang; Jun Zou; Yan-Qing Zheng; Gui-Chan Huang; Si-Run Meng; Jie-Hua Jin; Jing Li; Ming-Ju Zhou; Yu-Long Fu; Peng Zhang; Xiao-Yu Li; Tao Yang; Xiu-Wen Wang; Xiu-Han Yang; Jin-Wen Song; Xing Fan; Yan-Mei Jiao; Ruo-Nan Xu; Ji-Yuan Zhang; Chun-Bao Zhou; Jin-Hong Yuan; Lei Huang; Ya-Qin Qin; Feng-Yao Wu; Ming Shi; Fu-Sheng Wang; Chao Zhang
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 3.  Immunopathology and Immunotherapy of Inflammatory Skin Diseases.

Authors:  Ahreum Song; Sang Eun Lee; Jong Hoon Kim
Journal:  Immune Netw       Date:  2022-02-14       Impact factor: 5.851

4.  TLR2-induced CD8+ T-cell deactivation shapes dendritic cell differentiation in the bone marrow during sepsis.

Authors:  Anne-Charlotte Antoni; Ekaterina Pylaeva; Bettina Budeus; Jadwiga Jablonska; Ludger Klein-Hitpaß; Marcel Dudda; Stefanie B Flohé
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

5.  Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia.

Authors:  Andres Chang; Anton M Sholukh; Andreas Wieland; David L Jaye; Mary Carrington; Meei-Li Huang; Hong Xie; Keith R Jerome; Pavitra Roychoudhury; Alexander L Greninger; Jean L Koff; Jonathon B Cohen; David M Koelle; Lawrence Corey; Christopher R Flowers; Rafi Ahmed
Journal:  J Clin Invest       Date:  2022-09-15       Impact factor: 19.456

Review 6.  Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection.

Authors:  Ann W N Auma; Carey L Shive; Lenche Kostadinova; Donald D Anthony
Journal:  Viruses       Date:  2021-12-29       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.